Publication | Closed Access

In vitro activity of the mTOR inhibitor everolimus, in a large panel of breast cancer cell lines and analysis for predictors of response

Breast OncologyMedicinePharmacologyMtor Inhibitor EverolimusBreast CancerLarge PanelAnti-cancer AgentCancer TreatmentOncologyCell BiologyTumor MicroenvironmentTumor BiologyVitro Activity